-
1
Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study—IL PSO (Italian landscape psoriasis)
Published 2023-08-01Subjects: Get full text
Article -
2
-
3
Anti-IL17 and anti-IL23 biologic drugs for genital psoriasis: a single-center retrospective comparative study
Published 2023-05-01Subjects: Get full text
Article -
4
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study
Published 2023-03-01Subjects: Get full text
Article -
5
Long-term management of pediatric psoriasis with ixekizumab: a case report
Published 2023-12-01Subjects: Get full text
Article -
6
Risankizumab for the Treatment of Palmoplantar Pustular Psoriasis: A Report of Two Cases
Published 2023-04-01Subjects: “…psoriasis…”
Get full text
Article -
7
Upadacitinib for the treatment of concomitant psoriasis and atopic dermatitis: a case series
Published 2023-12-01Subjects: “…psoriasis…”
Get full text
Article -
8
Effectiveness and Safety of Biological Therapies in Very Severe Plaque Psoriasis: A Real-Life Retrospective Study
Published 2024-02-01Subjects: “…psoriasis…”
Get full text
Article -
9
Ixekizumab and ustekinumab in psoriasis: post-hoc comparison of onset and duration of treatment response
Published 2022-02-01Get full text
Article -
10
-
11
A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks
Published 2023-06-01Subjects: Get full text
Article -
12
-
13
-
14
The CANOVA Study Real-World Evidence of Biologic Treatments in Moderate-Severe Psoriasis in Italy: A Gender Perspective
Published 2022-05-01Subjects: Get full text
Article -
15
-
16
Anti-IL-23 and anti-IL-17 drugs for the treatment of non-pustular palmoplantar psoriasis: a real-life retrospective study
Published 2023-12-01Subjects: Get full text
Article -
17
Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers
Published 2023-12-01Subjects: Get full text
Article -
18
-
19
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study—IL PSO (ITALIAN LANDSCAPE PSORIASIS)
Published 2024-01-01Subjects: “…psoriasis…”
Get full text
Article -
20
Biologics for the Treatment of Severe Acrodermatitis Continua of Hallopeau: Report of Two Cases Successfully Treated with Ixekizumab and Ustekinumab
Published 2023-04-01Subjects: “…psoriasis…”
Get full text
Article